In The News
Clinical Lab Products | June 08, 2020
Quanterix, Billerica, Mass, is expanding its menu of ready-to-use Simoa kits to include tau phosphorylated at threonine 181 (p-tau 181), a highly specific biomarker for the study of Alzheimer’s disease pathology in cerebrospinal fluid, plasma, and serum.
featuring Kevin Hrusovsky | May 12, 2020
The Passionate Pioneers Podcast covers conversations with the innovators, the game changers, and the PIONEERS who are deeply passionate and relentless in solving the problems that our world is facing!
Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations
WCVB News 5 | May 12, 2020
Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations. Quanterix CEO Kevin Hrusovsky and Dr.
January 17, 2020
In this conversation with Anne Mostue, Quanterix Chairman and CEO, Kevin Hrusovsky highlights 2019 successes and plans for the future.
June 28, 2019
News of the Quanterix acquisition of UmanDiagnostics, which aired on NPR'S Morning Edition, Friday June 28.
Bloomberg | May 21, 2019
By Kanoko Matsuyama May 21, 2019, 4:00 PM EDT